RegulatoryOfficial

Spain's CODI-VET approves updated list of veterinary therapeutic gaps at 15th meeting

🇪🇸 AEMPS · Fri 30 Oct 2026

AEMPS's Veterinary Medicines Availability Committee updated its priority-needs document, adding new active-substance needs and removing others now covered by authorised products.

The Spanish Agency for Medicines and Health Products (AEMPS) said its Veterinary Medicines Availability Committee, CODI-VET, held its 15th meeting on 29 October 2026. The agency published its note on 30 October.

At the meeting, members discussed proposals from the committee's working groups on the document titled "Vacíos terapéuticos y otras necesidades prioritarias en las distintas especies animales", which covers therapeutic gaps and other priority needs across animal species. AEMPS said the committee approved a new version of it.

According to the agency, the aim of the revision was twofold: to add new needs for active substances for various diseases, and to remove other entries because authorised medicines now exist for them.

The note does not say which active substances, diseases or animal species were added or dropped, nor does it say when the revised document will be published or how it will be used.

What it means for your team

  • Companies with veterinary products in development or under authorisation should check the revised gaps document, once available, to see whether their target indications are listed as priority needs.
  • Entries removed because authorised medicines now exist show that the list is being kept in line with the market, so product launches can change a gap's status.
  • The source gives no detail on the specific revisions, so teams should wait for the full document before changing availability or authorisation plans.

Official source: AEMPS ↗

Article written by VigiEye from the official source (AEMPS). AI-assisted; check the source before acting.

More Regulatory All →